FEZF1 and gastric cancer: This finding supports the validity of other rare, but significant novel CISs we identified in our screen, such as Sfi1, Dock5 and Fezf1. Indeed, the human homolog of Fezf1 (known as ZNF312B) has been described as an oncogene in gastric cancer [32].